-
Signature
-
/s/ Louis J. Thorson, Attorney-in-Fact for Ban Seng Teh
-
Issuer symbol
-
STX
-
Transactions as of
-
13 Oct 2025
-
Net transactions value
-
-$224,958
-
Form type
-
4
-
Filing time
-
15 Oct 2025, 16:19:43 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Teh Ban Seng |
EVP & Chief Commercial Officer |
SEAGATE TECHNOLOGY HOLDINGS PLC, 47488 KATO ROAD, FREMONT |
/s/ Louis J. Thorson, Attorney-in-Fact for Ban Seng Teh |
15 Oct 2025 |
0001801425 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
STX |
Ordinary Shares |
Options Exercise |
$36,618 |
+532 |
+2.9% |
$68.83 |
18,573 |
13 Oct 2025 |
Direct |
F1 |
| transaction |
STX |
Ordinary Shares |
Options Exercise |
$56,464 |
+878 |
+4.7% |
$64.31 |
19,451 |
13 Oct 2025 |
Direct |
|
| transaction |
STX |
Ordinary Shares |
Sale |
$318,040 |
-1,410 |
-7.2% |
$225.56 |
18,041 |
13 Oct 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
STX |
NQ Options |
Options Exercise |
$0 |
-532 |
-8.3% |
$0.000000 |
5,858 |
13 Oct 2025 |
Ordinary Shares |
532 |
$68.83 |
Direct |
F2 |
| transaction |
STX |
NQ Options |
Options Exercise |
$0 |
-878 |
-4.2% |
$0.000000 |
20,212 |
13 Oct 2025 |
Ordinary Shares |
878 |
$64.31 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: